Bloomberg Intelligence Eli Lilly to Purchase Morphic, Green Hydrogen
Jul 8, 2024
Sam Fazeli discusses Eli Lilly acquiring Morphic. Sean O'Hara talks about the ETF market. Jared Dillian advises investors. The show covers pharmaceutical acquisitions, market stability, green hydrogen, and investment strategies.
Chapters
Transcript
Episode notes
1 2 3 4 5 6 7 8 9 10
Intro
00:00 • 2min
Eli Lilly's Acquisitions and Advancements in Pharma
01:48 • 9min
Discussion on Eli Lilly's Acquisition of Morphic and Drug Pricing in the Pharmaceutical Industry
11:12 • 3min
Navigating Equity Market Concerns and Investment Opportunities
14:11 • 16min
Analysis of the Impact of the Upcoming Election Year on Market Stability and Concentration Risk
30:15 • 2min
Discussion on Pacer ETFs, Thinkorswim Trading Platform, and Cybersecurity by CrowdStrike
32:21 • 2min
Navigating Concentration Risk and Market Uncertainties
34:12 • 8min
Investing at a Young Age and Green Hydrogen
41:43 • 2min
The Rise of Green Hydrogen
43:13 • 5min
Challenges and Solutions in Green Hydrogen Production and Purchase
48:00 • 3min